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children and adolescents with haematological malignancies (pedHM) are characterized by a severe 
loss of exercise ability during cancer treatment, lasting throughout their lives once healed and 
impacting their social inclusion prospects. The investigation of the effect of a precision-based exercise 
program on the connections between systems of the body in pedHM patients is the new frontier in 
clinical exercise physiology. This study is aimed at evaluating the effects of 11 weeks (3 times weekly) 
of combined training (cardiorespiratory, resistance, balance and flexibility) on the exercise intolerance 
in PedHM patients. Two-hundred twenty-six PedHM patients were recruited (47% F). High or medium 
frequency participation (HAd and MAd) was considered when a participant joined; > 65% or between 
30% and < 64% of training sessions, respectively. The “up and down stairs’’ test (TUDS), “6 min 
walking” test (6MWT), the “5 Repetition Maximum strength” leg extension and arm lateral raise test 
(5RM-LE and 5RM-ALR), flexibility (stand and reach), and balance (stabilometry), were performed and 
evaluated before and after training. The TUDS, the 5RM-LE and 5RM-ALR, and the flexibility exercises 
showed an increase in HAd and MAd groups (P < 0.05), while the 6MWT and balance tests showed 
improvement only in HAd group (P < 0.0001). these results support the ever‑growing theory that, in 
the case of the treatment of PedHM, ‘exercise is medicine’ and it has the potential to increase the 
patient’s chances of social inclusion.
One high-risk group susceptible to the effects of physical inactivity are children and adolescents (Ped) who 
survive haematological malignancies (HM). The growing survival trends are due to joint efforts to fight HM all 
over the world since the seventies: effective therapies, including hematopoietic stem cell transplantation (HSCT), 
multicentre randomized clinical trials, biological stratification and tailored therapies based on the evaluation of 
treatment response (mainly by the assessment of minimal residual disease), contributed to progressively improve 
outcomes. In Italy, cancer mortality rates in children were three-fold higher in the early seventies than in  20081. 
In addition, 5-year survival after cancer diagnosis increased in the last three decades, reaching 82% in children 
and 86% in  adolescents1. The expected number of new cancer cases in children aged between 0 and 14 years of age 
is approximately 7,000 in the period 2016–2020, while the corresponding figure for adolescents between 15 and 
19 years of age is 4,000 according to the Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP)1. 
In the European Society of Paediatric Oncology’s (SIOPE) perspective, today there are nearly 500,000 European 
PedHM survivors and in 2030 this number will be around 750,000. Out of this two-thirds of the patients will 
have some late effects and/or sequelae due to treatment and/or complications. Such late effects/sequelae are 
severe in half of the cases and have a strong impact on the patient’s daily  life2. SIOPE is committed to improving 
awareness of childhood cancer survivors in order for them to take responsibility for their own follow-up and to 
encourage national health systems to address the issues of long-term follow-up. As PedHM survivors move from 
the beginning of cancer treatment into their full potential as young adults, many of them would be well advised 
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to embrace many of the 2030 Sustainable Development Goals, as identified in the 2016 Bangkok declaration on 
physical activity for global health and sustainable  development3. A global glance at childhood cancer survivors 
invariably shows poor levels of fitness that are continuous and life-long, even after all cancer treatment, though 
there are a limited number of high-quality studies available in this area of  research4.
Physical activity levels in PedHM patients are most definitely influenced by access to safe, affordable and 
proper programs and places in which to be physically active. It may be useful, therefore, to introduce tailored 
training programs that might be carried out directly in the cancer centres, where PedHM patients already spend 
a long time for their treatment as inpatients or are followed up as outpatients. Implementation of innovative 
action plans targeting PedHM patients should foster collaboration across centres, guided by a shared vision 
to realize the multiplicative benefits of a more active world, especially in the hospital  settings5. The “Physical 
activity strategy for the WHO European region 2016–2025” has a specific priority in ensuring that opportuni-
ties for physical activity are included in care planning and practice and are available in long-term residential 
care  settings6. It seems that patients with physical disability, such as PedHM survivors, will be willing to engage 
in physical activity when they have a positive attitude, perceive that there is social support, and believe in their 
own ability to perform at a high  level7. Increased physical health also correlates with better emotional health 
and vocational identity, both affected by the indirect consequence of treatment intensity and age at  diagnosis8.
Reduced exercise ability in pedHM patients. Exercise capacity in PedHM patients is poorly addressed 
in scientific literature and long term follow up (over 3  years) of their physical performance is neglected. In 
comparison, we know that most adult acute myeloblastic leukemia survivors achieve full recovery of quality of 
life 3 years after intensive chemotherapy, not considering the fact that their exercise capacity remains limited: 
basic functions such as walking capacity show poor recovery gains on average and do not return to normal even 
3 years after the eradication of  disease9. Guardian and children’s/adolescents’ reports of quality of life (QoL) 
during chemotherapy for HM indicate that adverse effects due to drug toxicity are the primary factors affecting 
physical performance resulting in  fatigue10. Among the potential consequences of childhood cancer therapy are 
death,  cardiomyopathy11,12, pulmonary  diseases13–16,  myopathy12,17,18, osteonecrosis (ON)19 and motor nervous 
function  impairment20. Exercise tolerance is severely reduced in PedHM patients when compared to healthy 
 peers18,21,22. Strength is also reduced at the start of  treatment23,24, after being off-therapy for 1 year25 and even 
after 15  years of follow-up22. One year after stopping therapy, balance is also negatively affected in PedHM 
 patients26,27. Other consequences of cancer treatment are pain, fatigue, anxiety and fear, which further jeopardize 
the possibility to perform physical  activity28. When compared to their peers, PedHM patients are less active and 
more prone to engage in sedentary  behaviour29,30.
precision exercise in pedHM patients. Theoretically, precision exercise is a medicine that could improve 
the development of basic motor skills, as well as musculoskeletal development and the ability to achieve energy 
balance and weight control to counteract the acute and long-term effect of treatment and its burdening after-
math. A recent Cochrane review stated that the effects of physical exercise interventions for childhood can-
cer survivors are not yet  convincing31. Nevertheless, a very recent study on a larger cohort of patients showed 
how supervised in-hospital exercise intervention for children with cancer is safe and plays a cardioprotective 
 role32. There are positive intervention effects for body composition, flexibility, cardiorespiratory fitness, muscle 
strength, and health-related QoL (cancer-related items)22,33–37. Also, patients undergoing a HSCT can benefit 
from adapted  training38–40.
Precision exercise is the new frontier in clinical exercise physiology helping to induce oxidative metabolism 
(i.e. the main system of energy supply within cells) and boost the adaptive response of bones in vulnerable 
patients. Cancer treatment is associated with fluctuations of symptoms and moods during the course of the ill-
ness that can greatly influence an individual’s motivation to train. In children with cancer, some physical activity 
barriers included physical complaints and safety concerns that were more pronounced in on-therapy childhood 
cancer patients but also persisted off-therapy41. Collectively, these fluctuations emphasize the critical need for 
the precision exercise prescribed by experienced medical doctors/exercise physiologists that can be adapted in 
response to individual clinical  conditions42. The use of generic exercise prescriptions may actually be masking 
the full therapeutic potential of exercise treatment in the oncological setting. Essentially, the manipulation of 
training variables such as volume, intensity, frequency and recovery is an attempt to systematically structure 
training through phases to optimize physiological and psychological adaptations in an athlete that is also a patient 
with  cancer43. Finally, work recovery and rest are fundamental to restore the availability of nutrients and energy 
substrates to replace the components needed by the systems (proteins in the muscle).
A recent innovation in our training program addressed the specific issue pertaining to the impact of the 
physiological adaptation of bone in PedHM patients. The finding of hormones and cytokines secreted by bone 
and skeletal muscle during exercise, has recently added experimental evidence to the idea that a crosstalk exists 
between these  organs44. Bone through the hormone osteocalcin, promotes exercise capacity and in addition 
osteocalcin regulates the endocrine function of skeletal muscle because it boosts the expression of interleukin-6 
(IL-6). It seems that a feed-forward loop between bone and skeletal muscle is essential for exercise capacity. This 
endocrine regulation of exercise biology suggests adapted strategies for the inhibition of muscle loss process and 
bone damage, such as ON in PedHM patients. A specific stimulus is needed to impact the adaptive response of 
bone in healthy children, e.g. plainly the physical distortion of bone cells, rather than the metabolic or cardio-
vascular strains classically related with  exercise45. Perhaps the most compelling evidence that mechanical load-
ing is indispensable to bone integrity comes from studies of bed rest, space flight, and spinal cord injury, which 
showed that bone loss is rapid when mechanical forces acting on the skeleton are markedly  diminished46. In 
order to reduce the risk of bone damages in PedHM patients with articular ON, we provided adapted training, 
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but avoided the immobilization of these patients and included activities that create high ground-reaction forces, 
such as jumping, skipping, running and strengthening exercises.
Aim. This study is aimed at the evaluation of the effects of 11 weeks (3 times weekly) of precision exercise 
training on PedHM patients from the beginning to the end of treatment, including HSCT. Specific endpoints 
were: (1) individual exercise tolerance; (2) skeletal muscle strength; (3) balance and flexibility; (4) QoL, i.e. the 
physical, social and emotional aspects that are relevant to the process of resilience and community inclusion; and 
(5) satisfaction with the intervention as perceived by the participants and their parents.
Results
participants. This prospective longitudinal cohort study recruited 226 PedHM patients of both genders, all 
older than 3 years of age who were being treated at the haemato-oncology Maria Letizia Verga centre (MLV), 
Monza-Italy (Fig. 1). Two male participants aged 21 years old were also admitted due to their long clinical his-
tory of functional impairment for severe ON, meaning that they were still in follow up at the center. The number 
of PedHM patients eligible for precision exercise training were 183 and 159 accepted the invitation to participate 
in a precision exercise training program. Adherence to training sessions was calculated as number of sessions 
(%) attended on possible 33 sessions. Figure 1 shows the adherence level to the study from April 2017 to July 
2019. High frequency adherence (HAd) was indicated when a participant joined > 65% of the training sessions, 
between 64 and 30% was labelled medium adherence (MAd), between 29 and 15% was a low adherence (LAd). 
Table 1 shows the anagraphic and clinical characteristics of HAd, MAd and LAd groups. PedHM patients were 
affected with acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), Hodgkin lymphoma (HL) 
and non-Hodgkin lymphoma (NHL). As regards to the non-oncological diseases PedHM patients were affected 
with aplastic anemia, drepanocytosis, adrenoleukodystrophy and thalassemia major. Patients were divided by 
age into three groups (3–6; 7–11; 12–18 years). Dropouts were due to logistic reasons or in cases of death (4 
deceased PedHM patients). Participants were enrolled for more than 1 round when their functional capacity 
and exercise tolerance were far from the established goals due to an unfavorable clinical history charactherized 
by recurrent infections, disease relapse, severe Graft Versus Host Disease: 24 patients joined 2 or more rounds 
(47%). A control group of 18 healthy children (CTRL) of matching age and gender was evaluated as they partici-
pated in recreational (not competitive) activities. 
Each participant was informed by the referring paediatric haematologist about the possibility to participate 
in the research protocol. Subsequently, a sports medicine medical doctor performed an illustrative interview 
and an examination, including an anthropometric evaluation, baseline ECG and a respiratory test (spirometry), 
to evaluate the possible risks when performing precision training.
Figure 1.  PedHM patients eligible for precision exercise training. Age, gender and clinical phases of treatment 
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functional capacity and endurance. Figure  2 panel (a) shows the performance (time) during timed 
up and down stairs test (TUDS) and there is a statistically significant difference after training: in HAd and 
MAd groups the performance improved by 13% and 18%, respectively. When compared to CTRL the HAd and 
MAd groups at T0 and T1 showed a lower exercise capacity: the HAd and MAd at T0 were 43% and 52% less 
performant than CTRL, respectively; the HAd and MAd at T1 were 38% and 44%, respectively, less performant 
than CTRL. In the case of the HAd group, at T1 the lower exercise capacity is less marked than the MAd when 
compared to CTRL (p < 0.001 vs p < 0.0001). There is a statistical significance in the HAd_T1 values compared 
to MAd_T1, that HAd shows better performance after the training. Because the LAd group did not show any 
statistical difference at T0 and T1, the data is not presented in these results nor in the following ones.
Figure 2 panel (b) shows the performance (distance) during the 6-min walking test (6MWT). There was a 
statistically significant difference before and after training only in the HAd group; it improved by 7%. The MAd 
group did not show any performance improvement. When compared to CTRL, both HAd and MAd at T0 showed 
a lower performance capacity (15% and 26%, respectively). At T1, no difference in performance in group HAd 
when compared to CTRL was noticed while for the MAd group there is a statistically lower performance when 
compared to CTRL (21%).
Resistance. Figure 2 panel (c) shows the strength of quadricep muscles (1RM) during a leg extension test. 
There was a statistically significant difference before and after training for both HAd and MAd groups that 
improved by 14% and 18%, respectively. Compared to CTRL, HAd were 39% less strong at T0 but no differ-
ences were noticed at T1; while MAd at T0 showed a 48% lower performance capacity and at T1 46%. There is 
a statistical significance in the HAd_T1 values compared to MAd_T1, that HAd shows better performance after 
the training.
Figure 2 panel (d) shows the strength of deltoid muscles (1RM) during a lateral arm raise test and there is a 
statistically significant difference after training: in HAd and MAd groups where the performance improved by 
15% and 17%, respectively. Compared to CTRL the HAd and MAd groups at T0 and T1 showed a lower exercise 
capacity: at T0, the HAd and MAd were 35% and 52% less performant than CTRL, respectively. At T1 only the 
MAd were 46% less strong then CTRL. There is a statistical significance in the HAd_T1 values compared to 
MAd_T1, showing that HAd performed better after the training.
flexibility and balance. Figure  2 panel (e) shows the flexibility of posterior muscular chains during a 
stand and reach test and there is a statically significant difference after training: in HAd and MAd groups and the 
performance improved by 8% and 29%, respectively. Compared to CTRL, the HAd and MAd groups at T0 and 
Table 1.  Anagraphic and clinical characteristics of PedHM patients divided in high (HAd), medium (MAd) or 
low (LAd) frequency adherence to training sessions. ALL, acute lymphoblastic leukemia; AML, acute myeloid 
leukemia; HL, Hodgkin lymphoma; NHL, nonHodgkin lymphoma; HSCT, hematopoietic stem cell transplant.
HAd MAd LAd
Patients (num) 57 62 40
Age (years) 11.62 ± 4.34 9.89 ± 4.46 10.62 ± 4.62
Age (years, range) 4–22 3–22 3–22
Sex (% female) 44.44 71.19 45.61
Aged 3 < x < 6 years (%) 13.65 27.13 20.00
Aged 7 < x < 11 years (%) 34.60 37.30 38.30
Aged 12 < x < 22 years (%) 53.10 35.60 41.70
Aged 12 < x < 22 years, % Female 44.20 38.10 44.00
ALL (%) 51.85 67.80 59.65
HSCT (%) 11.11 23.73 24.56
Treatment protocol AIEOP BFM ALL 2009 and 2017
AML (%) 51.85 11.86 10.53
HSCT (%) 4.94 8.47 7.02
Treatment protocol AIEOP AML 2013
HL (%) 17.28 5.08 8.77
HSCT (%) 2.47 1.69 5.26
Treatment protocol EuroNet PHL C2
NHL (%) 6.17 3.39 5.26
HSCT (%) 1.23 1.69 5.26
Treatment protocol AIEOP LNH97
Non onco/HSCT (%/%) 14.81 11.86 15.79
HSCT (%) 7.41 10.17 8.77
Deceased (num) 1 2 1
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T1 did not show any difference. No statistical significance in the HAd_T1 values compared to MAd_T1, showing 
that the HAd performed better after the training.
The results of balance performance using a stabilometry test are shown in Table 2 and a statistically significant 
difference was seen at T1 for HAd, but not for MAd. It was impossible to use the stabilometric platform in CTRL 
because they could not have access to the centre for safety (immunological) reasons.
Very frail pedHM patients characteristics. Figure 3 shows a negative correlation between age and per-
formance during TUDS. The 3 age cohorts are represented before and after training and compared to CTRL. 
PedHM patients that could not take part in the T0 evaluation session due to walking inability are represented 
only after training (T1, full stars). The CTRL group showed a higher correlation  (r2 55.4) when compared to 
PedHM patients  at T0  (r2 0.16) and T1  (r2 0.25). A cut off value for each cohort of age has been calculated as 
mean + 1SD toward the worst performance at T0 and above this value fall the worst exercise capacities shown by 
the very frail PedHM patients The same correlation was made for all the variables represented in Fig. 2 and the 
regressions and cut off points are presented in Table 2.
Figure 2.  Performances during different tests by the PedHM patients before (T0, circles) and after (T1, squares) 
11 weeks of precision training. The PedHM patients has been compared to the CTRL group (triangles). Left side 
of the panel shows the PedHM patients at high frequency adherence to training sessions (HAd), while at right 
the medium frequency adherence (MAd). (a) Timed up and down stairs test (TUDS). (b) 6 min walking test 
(6MWT). (c) strength of quadricep muscles during a leg extension test. (d) strength of deltoids muscles during a 
lateral arm raise test. (e) flexibility of posterior muscular chains during a stand and reach test. Continuous lines 
of statistical significance: ordinary one way ANOVA. Dashed lines: paired t test. Speckled line: unpaired t test.
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Stabilometry T0_HAd T1_HAd T0_MAd T1_MAd
EC
Average 447.2 459.6 443.8 388.4
St dev 211.5 404.8 197.1 146.8
P value 0.9878 0.6387
EO
Average 337.2 265.1 328.1 281.3
St dev 220.4 104.1 145.2 111.3
P value 0.05 0.6257
EO vs EC
P value < 0.0001 < 0.0001
Linear 
regressions T0 T1 CTRL Are lines different?
6MWT
Equation Y = 13.45 × X + 339.0 Y = 10.68 × X + 411.1 Y = 35.64 × X + 266.9
YesP value  < 0.0001 0.0007  < 0.0001
R square 0.2259 0.1435 0.6474
Cut off values (m)
3–6 years: 261.98; 7–11 years: 386.84; > 12 years: 426.64
TUDS
Equation Y = − 0.3482 × X + 12.68 Y = − 0.2951 × X + 10.53 Y = − 0.3005 × X + 8.558
NoP value  < 0.0001 0.0007  < 0.0001
R square 0.1642 0.252 0.5542
Cut off values (s)
3–6 years:16.32; 7–11 years: 12.87; > 12 years: 10.56
Leg extension
Equation Y = 2.658 × X − 2.317 Y = 2.597 × X + 5.228 Y = 4.677 × X − 5.408
NoP value  < 0.0001  < 0.0001  < 0.0001
R square 0.417 0.3345 0.6677
Cut off values (kg)
3–6 years: 3.83; 7–11 years: 9.43; > 12 years: 21.62
Lateral raise
Equation Y = 0.2644 × X − 0.3149 Y = 0.2640 × X + 0.2334 Y = 0.3486 × X + 0.7754
NoP value  < 0.0001  < 0.0001  < 0.0001
R square 0.47 0.42 0.61
Cut off values (kg)
3–6 years: 0.75; 7–11 years: 1.09; > 12 years: 1.94
Flexibility
Equation Y = 0.0013 × X − 4.46 Y = 0.3149 × X − 3.643 Y = − 0.0173 × X + 1.326
NoP value 0.9944 0.2231 0.521
R square  < 0.0100 0.02 0.03
Cut off values (cm)
All ages: − 13.40
Balance EO
Equation Y = − 18.05 × X + 535.6 Y = − 10.31 × X + 401.2 np
NoP value  < 0.0001 0.005 np
R square 0.24 0.13 np
Cut off values (mm)
3–6 years: 716.85; 7–11 years: 427.85; > 12 years: 394.10
QoL T0_TOT T1_TOT T0_Phys T1_Phys
Children
Average 71.77 74.31 66.51 76.47
St dev 3.02 5.83 9.75 3.39
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QoL in children and parent perception, satisfaction. There was a statistical difference reported in 
QoL before and after training, for all groups, both by parents and children (Table 2).
Overall, the average VAS score for the 7 rounds that were investigated during the Sport Therapy study showed 
considerable satisfaction by both PedHM patients and their parents (9.30 ± 1.25 and 9.64 ± 0.60, respectively).
Discussion
An extensive number of PedHM patients have been included in this study, with varying degrees of frailty and 
our results conclusively support the idea that moderate to high-intensity exercise is not detrimental to PedHM 
patient health. The precision exercise program impacted both aerobic, strength, balance and flexibility char-
acteristics especially in those PedHM patients with HAd attending the training sessions. In line with what has 
been reported by previous studies of San Juan (2007), Chamorro-Viňa (2010), Perondi (2012), Kabak (2016), 
Fiuza-Luces (2017), Morales (2019) the precision exercise is safe and sustainable for PedHM patients including 
HSCT  recipients32,35–38,47.
The PedHM patients participated with enthusiasm in the precision exercise training: an overall high satisfac-
tion was seen, both from participants and parents points of view. This is a unique type of intervention, in a care 
system with a complex clinical organization that includes taking care of the full population of the centre (around 
100 new PedHM patients diagnosed yearly). The expected result of having satisfied families was an ambition, 
but it was not a guarantee. This is thanks in part due to the fact that frail patients are often overprotected by the 
clinical system and their parents, so the risks associated with training programs (risk of fall, muscle injuries, 
skin abrasions, community infections) can be an added stress factor into the complicated management of the 
PedHM patients. Thus, the result of VAS is a confirmation that the approach used to motivate PedHM patients 
and families, and the strategies planned by paediatricians with the sports medicine MDs were fruitful and were 
received with an appropriate level of acceptance. The PedHM patients and their caregivers found the training 
QoL T0_TOT T1_TOT T0_Phys T1_Phys
Average 67.94 68.42 62.46 71.12
St dev 5.56 7.01 10.94 4.39
P value 0.0019 0.0099
Table 2.  Balance performance at a stabilometry test before (T0) and after (T1) 11 weeks of precision 
training, linear regressions of performances during different tests vs PedHM patients ages and quality of life 
(QoL) questionnaires results. HAd and MAd, high and medium frequency adherence of training sessions; 
EC, eyes closed; EO, eyes open; TUDS, timed up and down stairs test; 6MWT, 6 min walking test.
Figure 3.  Correlation between age and performance during timed up and down stairs test (TUDS). Three age’s 
cohorts (3–7 years; 8–11 years; > 12 years) are represented before (empty circle and dotted line) and after (empty 
squares and continuous line) training and compared to CTRL (empty triangle and dotted-continuous line). 
PedHM patients that could not take part in the T0 evaluation session due to walking inability, are represented 
only after training (T1, full stars).
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sessions to be a pleasant excuse to go out from their homes and meet with the researchers involved and other 
participants facing the same physical challenges. Talking about their expectation to keep a certain degree of exer-
cise capacity even as it was constantly declining from the onset of disease, had a beneficial effect on individual 
level of anxiety about the exercises they can perform at home or in their rooms.
Certainly, a precision exercise training is challenging when considering the feasibility from the medical per-
sonnel point of view because physicians skilful in administering adapted and tailored exercises must be added to 
the personnel. The background of these personnel ranges from strong theoretical human physiology knowledge 
to clinical exercise pragmatic approach. The Sports medicine physician is a figure peculiar of the Italian health 
systems, based on preventive medicine, and this profession is evolving as a field which trains personnel overlook-
ing exercise in chronic patients including patients with cancer. Our center’s choice was to devote economical 
resources in introducing both Sports medicine physicians and personal trainers in order to administer the correct 
amount of exercise according to the clinical conditions of the PedHM patient. Considering that clinical condi-
tions of frail PedHM patients changes almost daily, a strong investment was made in a day-to-day consultation 
sessions between the oncologists and the sport therapy team. That way the prise en charge was safe, effective and 
in the exact range of competences for each figure involved.
Observation of the dropouts and the LAd group, showed that in certain phases of the clinical history of 
PedHM patients, precision exercise training is not suitable (acute infections, asthenia) and there are parents 
that are not very willing to consider the intervention as a therapy and/or are too apprehensive when the child 
shows signs of fatigue. We hope that once multi-centered studies show positive results of precision training on 
exercise capacity, both short and long-term, the number of dropouts will fall. PedHM with AML and HL gen-
erally afforded higher adherence of precision training, although ALL patients usually had medium and lower 
adherences to training. A fair percentage of HAd were represented by the frailest PedHM patients but they could 
partake in > 65% of the total training session: this was due to a few factors such as that they were very motivated 
patients, they had supportive parents, and many had a background in sport competition at regional/national 
level before being diagnosed. We can effectively see that all the phases of treatment allowed a high adherence to 
the training even if frail. PedHM patients in intensive course of treatment or at 1 year of HSCE could afford to 
participate mainly in training between 30 and 64% of adherence.
The TUDS evaluates specific capacities of our systems, i.e. the strength of inferior limbs during up (posi-
tive work or concentric contraction) and down (negative work or eccentric contractions). All these capacities 
deeply impact explosive exercise (i.e. anaerobic alactacide performance). The precision exercise greatly impacts 
these essential functions that allow a better QoL and the ability to sustain daily living activities. Compared to 
Zaino et al.48, our cohort of patients showed an average result of the TUDS test lower than that of children with 
functional deficit due to cerebral palsy. However, the frailest of our PedHM patients had a similar or worse 
performance. Our results correlate with those of San Juan (2007), Tanir (2012), Kabak (2016) considering the 
different age groups and the phases of  treatment35,47,49. The TUDS test evaluated specific characteristics of the 
strength of lower limbs during uphill and downhill exercises especially when it is necessary to perform explosive 
exercises (via metabolic anaerobic alactacide). Also, the execution of the TUDS test requires an adequate ROM 
of the lower limbs, coordination for fast movements, and anticipatory and reactive posture control. The training 
positively impacted these functions which allow patients to thrive in everyday life. The cut-off values shown in 
Table 2 are useful to objectively determine the fragility of PedHM patients during TUDS.
When looking at the values present in the aforementioned areas like fragility or when a clinical history was 
taken, these patients have had important medical complications that compromised their tolerance to physical 
activity (GVHS, ON, balance disruption, fear of heights, etc.). Traditionally, PedHM patients showed perfor-
mance value outside of the range of the performance of the CTRL group of the same age, especially at T0. At T1 
the values get closer to those of the healthy children and adolescents, but the question that remains is: how much 
time do the sick children need to reach a level that is considered normal? To understand this, it is necessary to 
think of a long term (5–10 years) follow-up of this same population. And this follow-up is currently not available. 
The starting point in HAd, at T0, shows an averaged better performance when compared to the MAd probably 
due to the fact that in MAd there is a higher percentage of intensive phase of treatment, including early HSCT. 
Thus, the higher increase of performance in MAd could be influenced by the starting point, i.e. the prevailing 
clinical condition at the time. The impact of the precision exercise program, thoroughly tailored to individual 
characteristics, could be noticeable especially in frail PedHM patients because they can range from severe dis-
ability as non-ambulatory to walking, after 11 weeks of training although with a medium adherence. Generally 
the HAd showed better performance in all the testes at T1 when compared to T0: the lower number of early HSCT 
and intensive treatment, plus a higher number of teens patients, could be the reason for these discrepancies.
As seen in Table 1, not statistically different ages were found in the 3 groups, but we had more teens patients 
in the HAd group so a stronger performance can be characteristic of post-puberty participants. Gender was also 
not the same in each of the 3 adherence groups: the MAd group had a higher percentage of females than the 
other 2 groups. But when considering just the post puberty cohort of age (> 12 years) the differences between 
groups decreased, so gender does not impact the differences between groups.
Figure 2 panel B shows the positive impact of precision exercise on aerobic capacity when high adherence to 
training is maintained. The exercise program is made up of 60 min/week specifically devoted to aerobic train-
ing. Based on our data, it seems that lower levels of aerobic training do not impact performance, specifically the 
oxidative pathway in PedHM patients. Once the aerobic training reaches the target of improving the efficiency of 
the transport and utilization chain of  O2, a less pronounced difference towards CTRL is noticed. On the contrary, 
a MAd training does not impact the oxidative metabolism of cardio-pulmonary and skeletal muscle systems. As 
noticed by Geiger et al.50, we noticed that in sick children the 6MWT almost completely represents a maximal 
exercise test and it could help to grade their level of impairment safely.
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Figure 3 panel A and Table 2 are useful in showing cut off values that one can use to determine the fragil-
ity of PedHM patients. When the clinical history of these patients was evaluated, they experienced various 
clinical complications (severe joint’s GvHD, ON, balance disorders, basophobia with vertigo, etc.). Generally, 
CTRL, especially teens, performed better than PedHM patients. The impact of drug treatment on health is well 
known while fewer studies relate to the impairment of respiratory function. But both are certainly related to 
the capacity of aerobic performance; walking, running and cycling. Thus, endurance training would increase, 
whereas profound deconditioning would decrease the peak capacity of  O2 extraction by skeletal  muscles51. It is 
possible that drug treatment ultimately impacts aerobic performance, rather than the explosive force necessary 
for exercises as jumping.
Strength. Muscular strength is one of the most studied parameters in sport science literature and in 
PedHM patients it is mostly affected by the myotoxic effects of drugs and muscle disuse. Some studies show 
that after a period of training there were significant increases in strength in children with solid  tumours37, in 
children with LLA 1 year after  diagnosis48 and in children in maintenance phase of  treatment36. The PedHM 
pateints have significantly less strength in their upper and lower limbs in comparison to healthy peers that are of 
the same age. Studies have shown that the force of a knee extension is reduced in PedHM patients during treat-
ment, especially in the beginning stages, when compared to the equivalent CTRL group. After the 11 weeks of 
precision training, the difference between PedHM patients and CTRL was reduced in a non-uniform way. The 
results of the children aged 3–6 years become much closer to those of the CTRL group of the same age at T1. The 
values of all age groups were better after training, despite remaining far from the results of the CTRL group. It is 
possible that atrophy of the muscles is more prevalent in older patients and that strength training in the volume 
and intensity proposed by the precision exercise training is not enough to bring their levels of strength back to 
what they were before being diagnosed. To understand how much time is necessary for total recovery, a long 
term follow up is necessary.
The strength of the lower limbs was evaluated with the leg extension test, a method also used by Perondi 
et al.36 on children with LLA in maintenance. Our project has also allowed us to demonstrate the feasibility and 
validity of this test on patients who underwent a HSCT (except for the most frail with ON for the lower limbs, 
for precautionary purposes). After the 11 weeks of training we found a marked improvement in the PedHM 
group. We can also make the same considerations for the strength of the upper limbs as explained in the previous 
paragraph. This improvement can be attributed to the exercises performed during training to stimulate the neuro-
muscular adaptations of strength of the lower limbs and to the training of the muscle groups necessary for the 
correct execution of the test. The group of healthy CTRL perform at a much higher level than the PedHM patients, 
a result that demonstrates the impact of muscular atrophy in the paediatric haematology oncology population.
On the whole, the PedHM patients demonstrate results that are on average lower compared to their healthy 
counterparts, both before and after precision training. As observed by the Leg Extension test, the PedHM 
patients values are far removed from the CTRL based on age.
The precision training strengthened the upper limbs in PedHM patients that trained and stuck to the program 
with HAd or MAd frequency. The strength of the deltoid muscle is positively influenced by precision training. 
The level of strength increases with age both in PedHM and the CTRL.
This is the first study that utilizes stabilometry to evaluate the static balance of PedHM patients. The differ-
ence between test results carried out at EO and at EC demonstrate the sensibility of the method in revealing 
variations of postural control. On average, the performance of PedHM HAd and MAd improves after 11 weeks 
of training. This improvement is more evident in PedHM HAd, yet another example of how precision training 
has a greater impact when it is done on a consistent, frequent basis. The results of the HAd group tended towards 
(p = 0.052), while the results of the MAd group were not significant. In terms of this variable, there is less of an 
effect of precision training. One hypothesis is that the impact of treatments on the neuromuscular system is not 
easily modifiable using the balance trading protocol. Adolescents are attributed with the best postural control 
of all the PedHM patients, both before and after training.
The stand and reach test revealed itself to be useful in determining the flexibility of PedHM patients, as it is 
doable by this very fragile population of  patients27. Flexibility in PedHM patients is often compromised due to 
illness and treatment of the illness. Wilson et al.52 analysed 365 children with LLA with levels of flexibility much 
lower than the healthy control group. Additionally, they demonstrated that the reduced flexibility was associated 
with an increased risk of limited functionality. Observing the correlation between the age and flexibility of the 
CTRL and PedHM shows interesting results. Flexibility is independent from the age of the children and teens. 
On the contrary, flexibility improves after 11 weeks of training and that improvement is clearly evident in the 
teens patients, who improved enough to surpass the performance of the CTRL group of the same age.
The QoL of PedHM is a variable investigated by many authors and researchers. Deisenroth et al. (2016), Ness 
et al. (2015) and San Juan et al. (2008) showed how it was significantly inferior to the QoL of CTRL in every single 
area, with the largest standard deviation in the area of physical well-being21,23,24. Other authors San Juan et al. 
(2007), Marchese et al. (2004), Tanir et al. (2012) and Fiuza-Luces (2017) did not find significant improvements 
in the QoL of their patients after  training34,35,37,49. In our study all of the PedHM patients showed improvements 
in their general QoL and particularly in the macro area of physical well-being. This result reflects their parent’s 
opinion as well. These results help us say, with confidence, that the experience of group training in the case of the 
PedHM patients provided them with a support net and close relationship that guaranteed increased motivation 
in therapy participation.
conclusion. Precision based exercise training is a challenge: it can be successful when multidisciplinary col-
laboration is exercised between paediatricians and sports medicine experts. A precision-based exercise program 
10
Vol:.(1234567890)
Scientific RepoRtS |        (2020) 10:12892  | https://doi.org/10.1038/s41598-020-69393-1
www.nature.com/scientificreports/
is a useful vast opportunity to improve the performance and the QoL of PedHM patients and should be consid-
ered as part of their care. We contend that PedHM patients, if supported by tailored training programs right from 
the diagnosis of cancer, can potentially become performant as high-level athletes. All PedHM patients can be 
included in precision exercise training when their age permit to sustain exercise (> 3 years) regardless of gender 
and the clinical history of fragility. After 11 weeks of training there is a positive impact on the chain of transport 
and use of  O2, strength, balance and flexibility. Patients that adhere to more than 64% of training sessions have a 
greater rate of improvement than those who only take part between 30 and 64%. The latter are mostly very frail 
PedHM patients. No advantages were recorded in PedHM patients that observed < 15% of adherence to training 
sessions. PedHM patients are overall less performant than healthy CTRL of the same age and gender. A cut off 
value has been discovered for each test used, in order to highlight the frailest PedHM patients that need extra 
precautions when exposed to training protocols. In HAd group, an amelioration of QoL was noticed, mainly due 
to the increased exercise tolerance that impacted their social behaviour. The satisfaction of the intervention that 
the Sport Therapy program has provided has been extremely high.
Methods
Every attempt to avoid any unnecessary discomfort and disturbance to all PedHM patients and parents was 
made according to the ERICE statement about the cure and care of long-term survivors of childhood  cancer53 
and according to the Declaration of Helsinki as a statement of ethical principles for medical research involving 
human participants. All children and both parents provided informed assent and written consent to participate 
in the project, respectively, which was approved by the University of Milano Bicocca ethics committee (regis-
tered number 2017/284). As regard Fig. 4, both child and her/his parents provided an informed consent for an 
online open-access publication. Personal data were treated according to the European standard principles of 
confidentiality (n. 2016/679).
precision exercise protocols. PedHM patients were divided in 2 precision exercise protocols depending 
on their clinical history and according to the intensity of their chemotherapy protocol. A “frail training protocol” 
was used for intensive lines of treatment: (1) patients in their early post-transplantation course (< 9 months); 
(2) patients affected with ALL and AML, during their front-line induction. A “standard training protocol” was 
used for medium intensive lines of treatment: (1) patients affected with ALL during their consolidation, high-
dose blocks, and re-induction, or after relapse; (2) patients with AML, after the induction phase; (3) patients in 
late post HSCT course; (4) patients affected with NHL and HL. PedHM patients off therapy were considered in 
their early follow up course (< 6 months). Besides the stratification according to the underlying disease, each 
patient was evaluated for his/her performance status at the onset and was continuously reassessed during each 
treatment, so that the risk stratification and the consequent training protocols was a dynamic process. Indeed, 
chemotherapy protocols, mainly those for ALL treatment, and the post-transplant course include high cumu-
lative steroid dose with severe repercussions on PedHM patient performance due to fatigue, nausea, myalgia, 
Figure 4.  Precision exercise training made by the same patient during 2 different times of her clinical history: 
2 days (in room) and 3 months (in gym, climbing wall) after haematological stem cells transplant.
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etc. Moreover, the vast majority of PedHM have low haemoglobin levels, despite frequent packed red blood cell 
transfusions. Toxic and infectious complications may affect every organ and system. Transplanted patients often 
suffer from lung infections, requiring  O2 support. PedHM patients during their long-term follow-up, especially 
ALL and transplanted patients, are affected by avascular ON.
PedHM patients were trained either directly in-patient rooms in one of the 3 wards (Bone Marrow Trans-
plant Center, Haematology and Day Hospital) or in the gym at MLV Centre (Fig. 4). Depending on the clinical 
condition of each PedHM patient, 2 different training modules were performed: each session, of 20–35 min 
(frail patients) or 50–60 min (standard patients) duration, was supervised by a medical doctor with a specializa-
tion in Sports Medicine and 1 sport scientist, with a ratio between patient/therapist of 1:2. Safety parameters 
such as heart rate (HR) and  O2 saturation, as well as training intensity and adherence to training sessions were 
documented daily in the patient’s record.
evaluation of the QoL and satisfaction. A child self-report (divided per age’s cohorts) and a parent 
proxy-report inventory (PedsQL 4.0) were used to measure the participants’  QoL54. The PedsQL 4.0 is a modular 
approach to measuring health-related quality of life in healthy children and adolescents and those with acute 
and chronic health conditions. There are 3 Summary Scores: total, physical health and psychosocial health sum-
maries. Each item has a score between 0 and 4, so the scale score is between 0 and 100. Higher scores indicate 
a better QoL.
The visual analog scale (VAS) method was used to evaluate the satisfaction of both participants and their 
parents after the precision training intervention. The visual analog scale (VAS) is a patient-reported scale from 
0 to 10 (where 0 is not satisfied and 10 is completely satisfied) that is increasingly being used to assess outcomes 
such as patient satisfaction after different medical  interventions55.
exercise tolerance capacity. The TUDS was performed accordingly to the Zaino’s et  al.  protocol48 in 
order to measure the general neuro-muscular aspect on the control of posture: it was, in fact, hypothesized that 
to carry out the test the participant must possess a certain strength of the lower limbs and the abdominal mus-
cles, as well as have a good coordination in the upper limbs and lower limbs movement, to go up and down the 
stairs as fast as possible.
The 6MWT was performed according to the Geiger’s et al.  protocol50 with a meter-counting wheel (Silverline 
868793 Mini measuring wheel). During the test  SpO2 and heart rate (HR) were continuously monitored by the 
Pulse saturimeter (Oxy True A-Blue Point Medical, Selmsdorf, Germany)50.
The strength of the limbs has been investigated through the execution of the test of the 5 maximum repetitions 
(5RM), which evaluates the maximum strength exerted by the participant before reaching muscular exhaustion 
according to Fiuza-Luces’ et al.  protocol37. For the lower limbs, the force of the extensor muscles of the knee 
was evaluated by using adaptable machinery that varied according to the size of the patient’s developmental age 
(Leg extension Alpha pro, multi-function bench, Kettler, Ense-Parsit, Germany). For the upper limbs (deltoid, 
trapezius and supraspinatus) the force test was carried out through the lateral arm raises with dumbbells (Toorx, 
Pozzolo Formigaro, Italy).
A stabilometric board was used in order to evaluate the balance of participants (TecnoBody, Dalmine (BG); 
Italy). Three consecutive tests were used, the first one not considered sufficient as available data. They performed 
a 30 s test with eyes open followed by 30 s eyes closed.
The stand and reach test was used in order to evaluate the flexibility of the kinetic posterior chain of the legs 
and trunk. The participants performed a reach test 2 times on a graduated scale (Baseline, Fabrication Enterprises 
Retail Sales Corp, USA) and the best measure was recorded.
Study design and statistical analysis. This was a single centre, analytic observational study, including 
both a cohort (PedHM, before and after exercise intervention) and a case–control (PedHM vs healthy CTRL) 
design. Values were expressed as mean (± SD). Sample size calculation determined that a sample of 15 par-
ticipants would be adequate to detect a difference of 25% of exercise capacity (6MWT or TUDS performance) 
between the participants and opposed to CTRL, with a power of 0.80 (α = 0.05). D’Agostino and Pearson’s omni-
bus normality test was used to check if the values come from a Gaussian distribution and when the variables did 
not pass the normality test they were treated with non-parametric test accordingly. The statistical significance 
of the difference between mean values, considering the different circumstances, was evaluated as follows: (1) in 
case of differences between PedHM at T0, T1 vs CTRL an ordinary one-way ANOVA, followed by a Kruskall 
Wallis’s test, with a Dunn’s multiple comparative test was used; (2) in case of differences between PedHM at T0 
vs PedHM at T1, a paired t test, two-tailed, followed by Wilcoxon matched-pairs rank test was used; (3) in case 
of differences between different group of PedHM (i.e. HAd vs MAd), an unpaired t test, followed by a Mann 
Whitney test was used. Regression analyses were performed using the least squared residuals method. The level 
of significance was set at p < 0.05. All statistical analyses were performed using a commercially-available software 
package (Prism 8.0: GraphPad, La Jolla, CA, USA).
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